Use of carnitines for the prevention and/or treatment of disorders caused by the andropause
AssigneeSigma-Tau Industrie Farmaceutiche Riunite S.p.A.
InventorsAleardo Koverech, Giulio Biagotti, Giorgio Cavallini
Life of this patent
Estimating the term…
Abstract
The use of propionyl L-carnitine in combination with acetyl L-carnitine, or one of their pharmaceutically acceptable salts, is disclosed for the preparation of a medicament, or of a nutritional supplement, for the prevention and/or treatment of the disorders of the male andropause caused by ageing or by chemical or surgical castration.
Claims10
-9. (canceled)
A method for the prevention and/or treatment of disorders caused by the andropause comprising administering to a subject in need thereof an effective amount of propionyl L-carnitine in combination with acetyl L-carnitine or one of their pharmaceutically acceptable salts.
Dependencies are inferred from the claim text.